Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Zowie E. Searcy
Observed name:
Zowie Searcy
Institution:
University of Pennsylvania
Observed institution:
University of Pennsylvania
ORCID:
0009-0006-4311-4552
Observed ORCID:
0009-0006-4311-4552
OpenAlex ID:
A5134207752
SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
·
Cancer Discovery
·
1
PDF
Supplementary Table 3 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Supplementary Figure S4 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Supplementary Figure S1 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Supplementary Figure S5 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Supplementary Table 4 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Supplementary Figure S6 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Supplementary Figure S2 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Supplementary Table 1 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Supplementary Table 2 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Supplementary Figure S3 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Supplementary Figure S7 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Supplementary Figure S3 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Supplementary Table 3 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Supplementary Table 2 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Supplementary Figure S4 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Supplementary Table 1 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Supplementary Figure S6 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Data from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Supplementary Table 4 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Supplementary Figure S5 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Supplementary Methods 1 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Supplementary Figure S1 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Supplementary Figure S2 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Supplementary Figure S7 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Show more works
View as search
Works count:
27
Citation count:
1
H-index:
1
I10-index:
Year
Topic
Type